Taysha Gene Therapies is spotlighting patient-centered Rett syndrome trial design through a Child Neurology Society webinar focused on natural history research

Taysha Gene Therapies is spotlighting patient-centered Rett syndrome trial design through a Child Neurology Society webinar focused on natural history research and emerging therapies. The outreach follows a TSHA-102 supply deal with Catalent; shares recently rose 6.7%.